Sunnybrook Research Institute

OrganisationROR

People

NCT07279714
Collaborator, Phase 2, Completed, 5 people, 12 Dec 2025
NCT07036003
Collaborator, Phase 1/2, Active, not recruiting, 34 people, 25 Jun 2025
NCT03053544
Collaborator, Phase 2, Completed, 15 people, 15 Feb 2017
NCT01353391
Collaborator, Phase 3, Completed, 500 people, 13 May 2011

BrightFocus Foundation
BrightFocus Foundation: Standard, Dementia risk mitigation in individuals with cardiovascular disease, CA2023003, US$98k, 2024–2026, 1 Jan 2024
Alzheimer's Drug Discovery Foundation
Prevention, Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists as Pharmacotherapies to Prevent Dementia, ADDF-21973956, US$100k, 2023–2025, 1 Jul 2023
Alzheimer's Association
AARG, Examining vascular risk and menopausal age on women’s increased risk for AD, AARG-23-1144933, 2023, 1 Jan 2023
Alzheimer's Association
ARCOM, Using Mobile Technology to Inform Driving Decision-Making in Dementia, ARCOM-23-1012154, 2023, 1 Jan 2023
Alzheimer's Association
PTC, Linking GSH and cognitive response: a pilot phase 2a study of NAC in VCIND, PTC-18-543823, 2018, 1 Jan 2018